Connect with WCG at AACI CRI 2026
WCG is attending AACI CRI 2026, where leaders come together to advance hematology and oncology research and address the operational realities of complex cancer trials.
With decades of experience supporting oncology programs, WCG helps streamline study start‑up, regulatory review, and site operations—so research teams can focus on what matters most: moving critical studies forward.
Hematology & Oncology IRB and Study Start‑Up Expertise
WCG provides integrated solutions designed for the demands of oncology research, including:
- Central IRB and IBC review for cancer studies
- End‑to‑end study start‑up and site enablement support
- Coverage analysis, budgets, and contracts
- Operational expertise aligned to academic and cancer center environments
Our teams understand the scientific complexity, regulatory rigor, and operational pressure that accompany hematology and oncology trials—and partner closely to reduce friction and accelerate activation.
Meet with WCG at AACI CRI
If you’ll be at AACI CRI 2026, schedule time to meet with WCG during the conference to discuss how we can support your oncology research initiatives.